2014 MDEA Jurors
Judging of each year’s MDEA competition is conducted by an impartial, multidisciplinary panel of expert jurors—comprised of a balance of clinicians, engineers, and designers—who carefully review all of the submissions and narrow them down to a select group of exceptional products in each of the 11 Medtech categories. The jury panel typically encompasses medtech professionals from a wide range of healthcare and design related fields, including clinical practice, biomedical engineering, human factors, industrial design, manufacturing, and other areas.
Members of the MDEA jury are selected each year by a panel of editors from UBM Canon. Such independence and impartiality is a leading reason for the industry wide acceptance and success that the MDEA program has enjoyed. MDEA jurors—past and present—have set a high standard for judging excellence and fair competition.
Watch these two videos featuring MDEA Jurors:
Meet the 2014 MDEA Jurors. Please check back as we update with new jurors.
Tor Alden—Mr. Alden is principal of HS Design (HSD), a product development firm specializing primarily in the medical and healthcare marketplace. HSD has built a 40-year record of innovative design leadership, solving complex usability and interface issues for medical devices and instrumentation, high-technology products, and new ventures. HSD’s focused specialization in medical user research, interface, industrial design, human factors, and mechanical engineering has led to many successful market launches.
As a Principal in HS Design, Alden has expertise in new product development, design research, strategy, project management and new business development. During his more than 20 years in product design and development, Alden has received over 30 patents and several design awards including MDEA, IDEA, CES Innovations and Good Design. Prior to joining HSD, Alden was Vice President at Logic Product Development in Minneapolis, where he directed user research, strategy, and industrial design. Earlier in his career he worked as a Lead Industrial Designer in the global design department at Lucent Technologies' Bell Laboratories.
An active member of the Industrial Designers Society of America, Alden has served as both chair and section chair, most recently as medical section chair. He currently sits on the advisory board of the department of design at Kean University, where he is an adjunct professor. He has served as a juror for the Medical Design Excellence Awards (MDEA), CEA Innovations Awards, and the Industrial Design Excellence Awards (IDEA).
Alden has been involved in several start-up companies, most recently as an officer of the surgical device company Vesatek, Inc., where he co-developed a novel guidewire manipulation device now in development. Alden received his Bachelor’s degree in industrial design from Syracuse University and his Master of Science degree in Technology Management from Stevens Institute of Technology.
Yadin B. David—Dr. David is the founder of Biomedical Engineering Consultants LLC, a Houston firm that provides assessment of medical technology management operations, regulatory compliance and forensic engineering services for hospitals and industry worldwide. For the previous 25 years, Dr. David headed the biomedical engineering department and the Center for Telehealth at Texas Children’s Hospital (Houston). He holds academic appointment at the University of Texas, School of Public Health. Dr. David has been a member of FDA advisory panel and is the recipient of the FDA commissioner’s special citation. He also received the ACCE/AAMI Robert L. Morris Humanitarian Engineering award, ACCE Life time achievement award and the 2013 distinguish leadership Award from the Medical Engineering Society of China. He has also served as an adviser to the World Health Organization (WHO), and as president of the Center for Telemedicine and eHealth Law (CTeL). He is a member of the Electrical Safety, EMC and MDDS WG committees of the Association for the Advancement of Medical Instrumentation (AAMI). He is a fellow of the American College of Clinical Engineering (ACCE); of the American Institute for Medical and Biological Engineering (AIMBE), of the Healthcare Technology Task Group of the International Union for Physical & Engineering Sciences in Medicine (IUPESM), a senior member of the Institute of Electrical and Electronics Engineers (IEEE); of the clinical engineering division of the International Federation of Medical and Biological Engineering (IFMBE). David holds a BSc in electrical engineering, an MSc in biomedical engineering, and an EdD in education from West Virginia University. He is a diplomate of the American Board of Forensic Engineering and Technology, is registered as a professional engineer, and is certified as a clinical engineer. He is also president emeritus of the nonprofit Healthcare Technology Foundation (www.thehtf.org). He has published numerous manuscripts and books. His areas of expertise include biomedical engineering, risk mitigation, telemedicine, electromagnetic interference, medical equipment evaluation, and incidents investigation.
Ross Donaldson, MD, MPH, CTropMed, FACEP—Dr. Donaldson is Director of the Emergency Medicine Global Health Program at Harbor-UCLA Medical Center and holds appointments in the UCLA Schools of Medicine and Public Health. Featured on CNN, BBC, NPR, and other media outlets, he is the critically acclaimed author of The Lassa Ward, a memoir about international humanitarian work, and the creator of WikEM, a popular smart-phone application for emergency clinicians. Dr. Donaldson has been the principal investigator on over $15 million dollars worth of grants, with research focusing on emergency, critical, and trauma care. He has worked around the globe, frequently in areas of conflict and recent disaster, and been the lead architect of national emergency care plans in several countries. In Iraq alone, he led the instruction of over ten-thousand doctors, EMTs, nurses, and community members, while developing pre-hospital and hospital-based emergency systems for the country. Among other honors, he received the Humanitarian Award from the California chapter of American College of Emergency Physicians in 2010.
Ross Donaldson, MD, MPH, CTropMed, FACEP | Director, Global Health Program & Fellowship, Department of Emergency Medicine | Harbor-UCLA Medical Center | 1000 W. Carson St. | Los Angeles, CA 90502 | USA | 310-222-3501| firstname.lastname@example.org | www.rossdonaldson.com | @DrRossDonaldson | LinkedIn
Craig M. Jackson, PhD—Dr. Jackson is the retired president of Hemosaga Diagnostics Corp., a start-up company in San Diego. He now operates a San Diego–based consulting practice and serves as the Program Director for The Hartwell Foundation, a foundation supporting innovative, high risk research related to diseases of children. Jackson has served as president and director of research and development for Reagents Applications Inc. and as scientific director for the American Red Cross Blood Services (Detroit) where he was also an adjunct professor of biochemistry at Wayne State University. He was a professor of biological chemistry and an associate professor of internal medicine at Washington University School of Medicine (St. Louis) prior to joining the American Red Cross. He has been a visiting professor at Kyushu University (Fukuoka, Japan) and the University of Hawaii. Jackson is a member of the editorial advisory board for IVD Technology magazine. He has written more than 75 original papers, contributed to more than 30 textbooks, writes regularly for both professional and trade journals, and holds several patents. He is a member of Working Group 1 of the Joint Committee for Traceability in Laboratory Medicine (JCTLM), an organization founded by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the Bureau International des Poids et Mesures (BIPM), and the International Laboratory Accreditation Cooperation (ILAC). JCTLM provides the mechanism by which the European Union’s In Vitro Device Directive requirement for traceability can be met. On the JCTLM, Jackson has led the team that has developed the quality system. He served on the USP Ad Hoc Advisory Committee on Heparin during the heparin adulteration crisis of 2008-2009. Jackson received a BS degree from Washington State University (Pullman, WA) and a PhD from the University of Washington (Seattle). He is a fellow of the National Academy of Clinical Biochemistry (Washington, DC) and also a fellow of the American Association for the Advancement of Science (Washington, DC).
Craig M. Jackson, PhD | Consultant for In Vitro Diagnostics, Hemostasis Testing, and Quality Systems for Laboratory Medicine | 5931 Seacrest View Rd. | San Diego, CA 92121-4355 | 858-638-0957 | email@example.com
Raj Khandwalla, MD, MA, FACC—Dr. Khandwalla is a board-certified cardiologist practicing with the Cedars-Sinai Medical Group (CSMG) and Cedars-Sinai Heart Institute. Dr. Khandwalla earned a bachelor's degree in molecular cell biology with an emphasis in neurobiology from the University of California, Berkeley. He earned his medical degree from the Tufts University School of Medicine and a master's degree in international relations from the Fletcher School of Law and Diplomacy. He completed his residency training at New York University (NYU) Medical Center, where he served as chief resident. At NYU, he developed web-based educational tools and helped to found the award-winning clinicalcorrelations.org. More recently, Dr. Khandwalla completed a cardiology fellowship at Georgetown University Hospital and Washington Hospital Center where he developed social networking software to improve communication and enable physicians to share information.
As an attending cardiologist at Cedars-Sinai Heart Institute, Dr. Khandwalla is currently a co-investigator in the NIH funded R-WISE study and is using wireless activity monitors to track the effectiveness of targeted therapies for women with microvascular dysfunction. In addition, he is co-director of the CSMG Heart Failure Program which has pioneered the use of biomarkers and handheld ultrasound to optimize therapy and reduce hospital re-admission rates.
Dr. Khandwalla has co-authored research papers on heart failure and has conducted research on mitral valve disease. He has an avid interest in developing strategies for effective lifestyle modification by using mobile technology to help patients monitor and change their habits in order to reduce their cardiovascular risk.
Raj Khandwalla, MD, MA, FACC | Cardiologist | Cedars-Sinai Medical Center | 250 N. Robertson Blvd., Suite 403 | Beverly Hills, CA 90048 | 310-385-3496 | firstname.lastname@example.org | @rajkmd | www.cedars-sinai.edu/Raj-Khandwalla-MD| www.linkedin.com/pub/raj-khandwalla-m-d-m-a/25/197/474
Stephanie Kreml, MD—Dr. Kreml’s broad career spans across clinical research, product engineering, medical technologies, and commercialization strategy roles. She returned to Popper and Company as a principal in 2013 after having previously served with the firm from 2008 to 2010. In her current role, she develops and implements business strategy for start-up companies and new business units in existing companies; consults in areas of clinical need, commercialization, and technology assessment; performs due diligence for investment and acquisition targets in the life science industry; critically evaluates unmet clinical needs and technologies; and provides guidance to accelerate new product development activities. She also recently began serving as a guest columnist for InformationWeek Healthcare, providing thought leadership on various topics related to digital health.
From 2010 to 2013, Dr. Kreml held the positions of Associate Medical Director and Center Medical Director at Concentra in Austin, Texas, and she continues to practice as a staff physician part-time. Prior to medical school, she held engineering positions with Motorola and Texas Instruments.
Dr. Kreml received her Doctor of Medicine from the Baylor College of Medicine and a Bachelor of Science in Electrical Engineering from The University of Texas at Austin. During her residency in general surgery, she was a research fellow at Baylor College of Medicine’s Human Genome Sequencing Center and in the Mechatronics and Haptic Interfaces Lab at Rice University.
Stephanie Kreml, MD | Principal | Popper and Company | PO Box 163721 | Austin, Texas 78716 | 512-658-0048 | email@example.com | @SKremlMD | www.popperandco.com | www.linkedin.com/pub/stephanie-kreml-md/7/a23/202
Jonathan Y. Lee, MD, ABEM—Dr. Lee is the Quality Improvement Director at Scripps Mercy Hospital, a tertiary care, level-one trauma center, in San Diego. He has served as the Chairperson of the Emergency Medicine Department and Education Director. Dr. Lee has had varied experiences in his career. He has volunteered for numerous disasters and charities including International Relief Team, International Latin American Concerns, Scripps Medical Relief Team, and Disaster Medical Relief Team at federal and state level among others. With expertise and training in Tropical Medicine, he has traveled extensively to provide medical care to third world countries. He has a strong affinity for teaching, and has been the recipient of numerous awards as the best educator by multiple institutions. He has also been honored by his peers as one of the top doctors in San Diego County, California. His current interests include behavioral decision making processes in medicine, and application of ultrasound in community hospital emergency departments. Additionally, his facility in clinical medicine and current patent work in medical devices confers him an appropriate perspective as an MDEA juror.
Jonathan Y. Lee, MD, ABEM | Quality Improvement Director | Scripps Mercy Hospital | 4077 Fifth Ave. | San Diego, CA 92103 | USA | 619-686-3800 | firstname.lastname@example.org
Pascal Malassigné, FIDSA—Mr. Malassigné is the senior professor and chair of industrial design at the Milwaukee Institute of Art and Design, a career research scientist and industrial designer at the Milwaukee Veterans Affairs Medical Center, and an adjunct assistant professor of rehabilitation at the Medical College of Wisconsin in Milwaukee. He is one of the nation’s foremost designers of assistive and wheeled mobility for the elderly and those with disabilities. For over 25 years, his research has been funded by the U.S. Department of Veterans Affairs and has led to the design of patented products from commode-shower wheelchairs to bathing fixtures, mobility carts for spinal cord injured individuals. Malassigné has more than 35 years of experience teaching industrial design, and taught at Georgia Tech and Virginia Tech universities before coming to Milwaukee in 1991. He is a visiting evaluator for the National Association of Schools of Art & Design, for the accreditation of industrial design programs. He has authored more than 70 articles and papers and has made numerous presentations nationally and internationally on topics ranging from design education to rehabilitation technology. Malassigné is a member of the Human Factors and Ergonomics Society, the Rehabilitation Engineering Society of North America, and the Industrial Designers Society of America (IDSA), in which he was made a fellow member in 2001 in honor of his service to the industrial design profession and IDSA. He was the first president of the Design Foundation, IDSA’s nonprofit organization. In 2006, Design Intelligence named him one of the nation’s most admired industrial design educators.
Pascal Malassigné, FIDSA | Senior Professor & Chair, Industrial Design | Milwaukee Institute of Art & Design | 273 E. Erie St. | Milwaukee, WI 53202 | 414-291-8069 | email@example.com | www.miad.edu | www.linkedin.com/pub/pascal-malassigné-fidsa/2/741/398
Richard Meyst—Mr. Meyst is an accomplished engineer/program manager/entrepreneur and has been facilitating the advanced design and development of a wide range of successful medical technology products for the health care industry over the last 40+ years. Mr. Meyst is president and CEO of Fallbrook Engineering Inc. (Escondido, CA), a contract product design, development, management, and engineering services consulting firm specializing in healthcare products. He is also president and CEO of Cellection Systems, a start-up company commercializing a cord blood collection product for cellular therapy. Meyst is an accomplished mechanical engineer and developer of a wide range of products for the healthcare and consumer products industries. He has experience in roles including R&D researcher, product designer, inventor, project manager, Principal Investigator, and small business entrepreneur. He is an expert in FDA medical product requirements, project management, product conception, design and development, product prototyping, design and process validation, risk analysis, failure analysis, production startup, cost reduction and manufacturing engineering. Mr. Meyst earned his BS and MS in mechanical engineering from the University of Wisconsin, Madison. He has published technical papers, presented at numerous industry meetings, holds sixteen US Patents, and has been consulting to industry for over 25 years.
Richard Meyst | President and CEO | Fallbrook Engineering Inc. | 355 W. Grand Ave., Ste. 4 | Escondido, CA 92025 | 760-489-5400 | Toll free: 800-906-6789 | firstname.lastname@example.org | @FallbrookEngInc | www.linkedin.com/in/richardmeyst/ | www.facebook.com/fallbrookengineering | www.fallbrookeng.com
Mary Beth Privitera, M. of Design—Mary Beth is currently the Director, of the Medical Device Engine at the University of Cincinnati Medical Center, where she holds a joint appointment as Associate Professor with the College of Medicine and the College of Engineering and Applied Science. The Medical Device Engine is a professional design team aimed at optimizing device design by applying proven design research methodology, applying applicable human factors standards, and by promoting both collaborative and patient-centered medical device development processes. This effective research team works directly with industry and brings them into the practice of medicine for the purposes of medical device design. For the last nine years, she has been the Co-Director of the Medical Device Innovation and Entrepreneurship Program (MDIEP) at the University of Cincinnati. The program partners multidisciplinary student teams with physician innovators, and focuses on translating research efforts into viable product development opportunities. To date, the program has demonstrated results for clinical specialists in vascular surgery, interventional radiology, general surgery, cardiothoracic surgery, emergency medicine, pulmonary care, rehabilitative medicine, and neurology. Privitera’s research focus is in collaborative medical device design and the application of human factors in design. She is a member of the Association for the Advancement of Medical Instrumentation Human Factors Committee and has coauthored various sections in HE 75 and recently a TIR on Contextual Inquiry. To date, she has been associated with more than 40 product releases, holds several patents and provisional patents, and has published and lectured on a variety of topics including design research, transdisciplinary/collaborative design, innovation methodology, and surgical techniques.
Mary Beth Privitera, M. of Design | Associate Professor, Emergency Medicine, Biomedical Engineering, Industrial Design | Medical Device Engine | University of Cincinnati | Department of Emergency Medicine | 231 Albert Sabin Way, PO Box 670769 | Cincinn ati, OH 45267 | 513-258-5824 |email@example.com | www.ucemergencymedicine.org | www.linkedin.com/pub/marybeth-privitera/2/4a1/b61
Mark S. Vreeke, PhD—Dr. Vreeke is a cofounder of the Chemical Angel Network. The Chemical Angel Network brings together entrepreneurs and investors who are working on growing companies with a strong Chemistry component. Mark’s specialties are in the broad areas of medical devices/diagnostics, information technology, and energy transportation.
Mark is also one of the founding partners at Rational Systems. Rational Systems’ enterprise software is installed on five major interstate gas pipelines and multiple smaller gas transportation and storage assets. It is currently responsible for managing the commercial operations of 15-20% of the entire US natural gas market.
Prior to and during his tenure at Rational Systems, Mark was employed by several medical device and diagnostic firms including Pepex Biomedical, SpectRx, TheraSense, Bayer and Hospira. His roles ranged from Research Scientist to Senior VP of R&D. Of particular relevance was TheraSense. Mark assisted with the transfer the Wired Enzymetm technology from the University of Texas to TheraSense. This technology formed the basis for a successful product launch and the eventual purchase of the company by Abbott for $1.2 billion in cash.
Mark earned a BS in Chemistry from Calvin College and a PhD in Chemistry from the University of Texas at Austin. Academic honors include a Welch Fellow, a Woodrow Wilson Fellow and the accreditation of Professor by the ACQ in Spain.
Mark S. Vreeke, PhD | coFounder | Chemical Angel Network | 1400 East Angela Blvd. | South Bend, IN 46617 | 832-752-2915 |mark.vreeke@ChemicalAngels.com | www.ChemicalAngels.com | www.linkedin.com/in/markvreeke
George L. Walls—George Walls is the Director, Product and Market Development for ZOLL, an Asahi Kasei Group company. For over 25 years he has led innovation teams across multiple disciplines to develop, launch, and market advanced technology and medical devices. He is passionate about cross-functional excellence that results in the delivery of “whole products” combining devices, services, training, and support to create meaningful user experiences and life-saving outcomes. Today his portfolio includes tools for critical care and includes Intravascular Temperature Management, a unique balloon catheter for Cerebral Vasospasm, and a Cardiopulmonary bypass system. George is a prior MDEA winner and previously worked for St. Jude Medical and Laerdal Medical Corporation. He holds several patents, a BS/BA from the University of Dayton and an Executive MBA from the University of Houston.
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
George L. Walls | Director, Product and Market Development | ZOLL | 2000 Ringwood Avenue | San Jose, CA 95131 | USA | 408-541-2140| firstname.lastname@example.org | www.zoll.com | www.linkedin.com/pub/george-walls/0/54/547/
Michael E. Wiklund, PE, CHFP—Mr. Wiklund is General Manager of UL’s human factors engineering practice (formerly Wiklund Research & Design Inc. in Concord, MA). The group helps companies develop safe, effective, usable, and appealing medical products. Board-certified in his profession, Wiklund’s experience as a project manager, principal researcher, and designer extends beyond medical devices to include consumer and scientific products, personal and business software, corporate and e-commerce Web sites, communications technology, and industrial equipment and workplaces. As Professor of the Practice at Tufts University, heteaches courses on human factors in medical technology and software user interface design. Wiklund has been a contributing editor to Medical Device and Diagnostic Industry magazine (MD&DI) since 1993, and is a member of the publication’s editorial advisory board. He has published numerous articles, books, and technical papers, and has also presented papers at professional conferences in the medical device, human factors, and scientific instrumentation fields. He co-authored Usability Testing of Medical Devices and Designing Usability into Medical Products and co-edited Handbook of Human Factors in Medical Device Design. He is a voting member of the AAMI and IEC human factors engineering committees. Holding BS (civil engineering) and MS (engineering design/human factors) degrees from Tufts University, Wiklund is also a professional engineer. In 2004, MD+DI named Wiklund to its list of 100 notable people in the medical device industry.
Michael E. Wiklund, PE, CHFP | General Manager – Human Factors Engineering | UL–Wiklund R&D | 152 Commonwealth Ave. | Concord, MA 01742 | Phone: 978-371-2700 | email@example.com | www.wiklundrd.com
2014 MDEA Alternate Jurors
Dr. Ogan Gurel, MD—Dr. Gurel is a Director in the Management of Technology (MOT) Research Center / CTO Office at the Samsung Advanced Institute of Technology (SAIT), holding, also, an academic appointment as Visiting Professor at the Samsung Advanced Institute for Health Sciences and Technology (SAIHST) of SungKyunKwan University. Previous positions include VP & Medical Director at Sg2 and Associate at Booz, Allen & Hamilton where he consulted for clients spanning the healthcare services, payer, biopharma and medical device sectors. Dr. Gurel’s expertise spans a wide spectrum of the industry: clinical, business, executive management, marketing and R&D, with direct experience along several verticals, including medical devices, mobile health, healthcare IT, medical imaging, and pharmaceuticals. His scientific research interests focus on structural biology, specifically protein electrodynamics and terahertz medicine. Dr. Gurel holds an M.D. (Alpha Omega Alpha) from the Columbia University College of Physicians & Surgeons as well as an M.Phil (Biochemistry & Molecular Biophysics) where he researched x-ray crystallographic structural studies of cytokines with Wayne Hendrickson. He earned his B.A. cum laude in Biochemical Sciences from Harvard University where he conducted research on DNA structure with Martin Karplus, 2013 Nobel Prize in Chemistry, and Michael Weiss, and after graduating serving as Visiting Researcher at the Institut Laue-Langevin working with Giuseppe Zaccai on membrane proteins. With teaching appointments at Columbia, Roosevelt, Harvard, and SAIHST, Dr. Gurel has taught cellular and molecular biology, neuroanatomy, bioinformatics and mathematical modeling. Published in the peer-reviewed scientific literature, and with contributions to the Boston Globe and Wall Street Journal, Dr. Gurel has presented invited talks at leading institutions worldwide covering a number of topics related to healthcare technology trends, the future of medicine, and healthcare market dynamics. Dr. Gurel served as an MDEA juror from 2007 to 2008.
Dr. Ogan Gurel, MD | Director, MOT Research Center – CTO Office | Samsung Advanced Institute of Technology | Visiting Professor | Samsung Advanced Institute of Health Sciences and Technology | Republic of Korea | firstname.lastname@example.org | www.linkedin.com/in/ogangurel
Stuart Karten—Stuart Karten is the President of the award-winning Los Angeles-based product design and innovation consultancy, Karten Design. For 30 years, he has partnered with medical device and consumer electronics companies, from start-ups to Fortune 500 companies, to seize new business opportunities, commercialize new technology, and develop differentiated products that create positive experiences for the people who use them. His designs, which include easy-to-use emergency defibrillators, clinical equipment that saves physicians’ time, and hearing aids that banish stigma, are developed to improve adoptability and advance the standard of care. Stuart is a graduate of the Rhode Island School of Design. He worked for Gould Medical Products, Mattel, and Baxter Medical Products until founding Karten Design.
Stuart Karten | Principal | Karten Design | 4204 Glencoe Ave. | Marina Del Rey, CA 90292 | 310-827-8722 | email@example.com | www.kartendesign.com | @StuartKarten | www.linkedin.com/in/kartendesign